Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Leo A Hardegger

Showing results (1-10 of 6) with videos related to

Pageof 1
Sort By:
Organic Letters|June 19, 2015
Modular Synthesis of Highly Substituted Pyridines via Enolate α-AlkenylationLeo A Hardegger, Jacqueline Habegger, Timothy J Donohoe
Chemical Communications (Cambridge, England)|December 22, 2009
Self-association based on orthogonal C=O...C=O interactions in the solid and liquid stateChristoph Fäh, Leo A Hardegger, Marc-Olivier Ebert, et al.
Organic & Biomolecular Chemistry|September 19, 2009
New organofluorine building blocks: inhibition of the malarial aspartic proteases plasmepsin II and IV by alicyclic alpha,alpha-difluoroketone hydratesChristoph Fäh, Leo A Hardegger, Lukas Baitsch, et al.
Chemistry (Weinheim an Der Bergstrasse, Germany)|November 19, 2015
Addressing the Glycine-Rich Loop of Protein Kinases by a Multi-Facetted Interaction Network: Inhibition of PKA and a PKB MimicBirgit S Lauber, Leo A Hardegger, Kazi A Alam, et al.
Chemmedchem|September 8, 2011
Halogen bonding at the active sites of human cathepsin L and MEK1 kinase: efficient interactions in different environmentsLeo A Hardegger, Bernd Kuhn, Beat Spinnler, et al.
Journal of Medicinal Chemistry|February 6, 2018
The Discovery of N-(1-Methyl-5-(trifluoromethyl)-1H-pyrazol-3-yl)-5-((6- ((methylamino)methyl)pyrimidin-4-yl)oxy)-1H-indole-1-carboxamide (Acrizanib), a VEGFR-2 Inhibitor Specifically Designed for Topical Ocular Delivery, as a Therapy for Neovascular Age-Related Macular DegenerationChristopher M Adams, Karen Anderson, Gerald Artman, et al.
Pageof 1

Showing results (1-10 of 6) with videos related to

Sort By:
Pageof 1
Organic Letters|June 19, 2015
Modular Synthesis of Highly Substituted Pyridines via Enolate α-AlkenylationLeo A Hardegger, Jacqueline Habegger, Timothy J Donohoe
Chemical Communications (Cambridge, England)|December 22, 2009
Self-association based on orthogonal C=O...C=O interactions in the solid and liquid stateChristoph Fäh, Leo A Hardegger, Marc-Olivier Ebert, et al.
Organic & Biomolecular Chemistry|September 19, 2009
New organofluorine building blocks: inhibition of the malarial aspartic proteases plasmepsin II and IV by alicyclic alpha,alpha-difluoroketone hydratesChristoph Fäh, Leo A Hardegger, Lukas Baitsch, et al.
Chemistry (Weinheim an Der Bergstrasse, Germany)|November 19, 2015
Addressing the Glycine-Rich Loop of Protein Kinases by a Multi-Facetted Interaction Network: Inhibition of PKA and a PKB MimicBirgit S Lauber, Leo A Hardegger, Kazi A Alam, et al.
Chemmedchem|September 8, 2011
Halogen bonding at the active sites of human cathepsin L and MEK1 kinase: efficient interactions in different environmentsLeo A Hardegger, Bernd Kuhn, Beat Spinnler, et al.
Journal of Medicinal Chemistry|February 6, 2018
The Discovery of N-(1-Methyl-5-(trifluoromethyl)-1H-pyrazol-3-yl)-5-((6- ((methylamino)methyl)pyrimidin-4-yl)oxy)-1H-indole-1-carboxamide (Acrizanib), a VEGFR-2 Inhibitor Specifically Designed for Topical Ocular Delivery, as a Therapy for Neovascular Age-Related Macular DegenerationChristopher M Adams, Karen Anderson, Gerald Artman, et al.
Pageof 1